These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29222177)

  • 21. Duchenne muscular dystrophy: issues in expanding newborn screening.
    Kemper AR; Wake MA
    Curr Opin Pediatr; 2007 Dec; 19(6):700-4. PubMed ID: 18025940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy].
    Sun SC; Peng YS; He JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):35-7. PubMed ID: 18289468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early symptoms of Duchenne muscular dystrophy--description of cases of an 18-month-old and an 8-year-old patient.
    Iwańczak F; Stawarski A; Potyrała M; Siedlecka-Dawidko J; Agrawal GS
    Med Sci Monit; 2000; 6(3):592-5. PubMed ID: 11208376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic and Early Clinical Manifestations of Females Heterozygous for Duchenne/Becker Muscular Dystrophy.
    Papa R; Madia F; Bartolomeo D; Trucco F; Pedemonte M; Traverso M; Broda P; Bruno C; Zara F; Minetti C; Fiorillo C
    Pediatr Neurol; 2016 Feb; 55():58-63. PubMed ID: 26718981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Limb-girdle muscular dystrophy in MRI].
    Herzog H; Schröder RJ
    Rofo; 2003 Oct; 175(10):1432-4. PubMed ID: 14556115
    [No Abstract]   [Full Text] [Related]  

  • 26. A sensitive assay of tumor necrosis factor alpha in sera from Duchenne muscular dystrophy patients.
    Saito K; Kobayashi D; Komatsu M; Yajima T; Yagihashi A; Ishikawa Y; Minami R; Watanabe N
    Clin Chem; 2000 Oct; 46(10):1703-4. PubMed ID: 11017956
    [No Abstract]   [Full Text] [Related]  

  • 27. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Duchenne muscular dystrophy: a 30-year population-based incidence study.
    Dooley J; Gordon KE; Dodds L; MacSween J
    Clin Pediatr (Phila); 2010 Feb; 49(2):177-9. PubMed ID: 20080524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measuring the effectiveness of diagnostic markers in the presence of measurement error through the use of ROC curves.
    Reiser B
    Stat Med; 2000 Aug; 19(16):2115-29. PubMed ID: 10931515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype.
    Schwartz M; Hertz JM; Sveen ML; Vissing J
    Neurology; 2005 May; 64(9):1635-7. PubMed ID: 15883334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vibration therapy tolerated in children with Duchenne muscular dystrophy: a pilot study.
    Myers KA; Ramage B; Khan A; Mah JK
    Pediatr Neurol; 2014 Jul; 51(1):126-9. PubMed ID: 24830767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Composite biomarkers for assessing Duchenne muscular dystrophy: an initial assessment.
    Shklyar I; Pasternak A; Kapur K; Darras BT; Rutkove SB
    Pediatr Neurol; 2015 Feb; 52(2):202-5. PubMed ID: 25447928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.
    Anaya-Segura MA; García-Martínez FA; Montes-Almanza LA; Díaz BG; Avila-Ramírez G; Alvarez-Maya I; Coral-Vazquez RM; Mondragón-Terán P; Escobar-Cedillo RE; García-Calderón N; Vazquez-Cardenas NA; García S; López-Hernandez LB
    Molecules; 2015 Jun; 20(6):11154-72. PubMed ID: 26091074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetics and emerging treatments for Duchenne and Becker muscular dystrophy.
    Wein N; Alfano L; Flanigan KM
    Pediatr Clin North Am; 2015 Jun; 62(3):723-42. PubMed ID: 26022172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpretation of acid α-glucosidase activity in creatine kinase elevation: A case of Becker muscular dystrophy.
    Oitani Y; Ishiyama A; Kosuga M; Iwasawa K; Ogata A; Tanaka F; Takeshita E; Shimizu-Motohashi Y; Komaki H; Nishino I; Okuyama T; Sasaki M
    Brain Dev; 2018 Oct; 40(9):837-840. PubMed ID: 29778277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Creatine kinase test diagnostic accuracy in neonatal screening for Duchenne Muscular Dystrophy: A systematic review.
    de Freitas Nakata KC; da Silva Pereira PP; Salgado Riveros B
    Clin Biochem; 2021 Dec; 98():1-9. PubMed ID: 34626608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum creatinine level: a supplemental index to distinguish Duchenne muscular dystrophy from Becker muscular dystrophy.
    Zhang H; Zhu Y; Sun Y; Liang Y; Li Y; Zhang Y; Deng L; Wen X; Zhang C
    Dis Markers; 2015; 2015():141856. PubMed ID: 25852218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical features of patients with dystrophinopathy sharing the 45-55 exon deletion of DMD gene.
    Taglia A; Petillo R; D'Ambrosio P; Picillo E; Torella A; Orsini C; Ergoli M; Scutifero M; Passamano L; Palladino A; Nigro G; Politano L
    Acta Myol; 2015 May; 34(1):9-13. PubMed ID: 26155064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aminotransferases and muscular diseases: a disregarded lesson. Case reports and review of the literature.
    Veropalumbo C; Del Giudice E; Esposito G; Maddaluno S; Ruggiero L; Vajro P
    J Paediatr Child Health; 2012 Oct; 48(10):886-90. PubMed ID: 20500440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.